Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 2;46(4):749-755.
doi: 10.1016/j.burns.2020.03.014. Online ahead of print.

Experience and Suggestion of Medical Practices for Burns During the Outbreak of COVID-19

Affiliations
Free PMC article
Review

Experience and Suggestion of Medical Practices for Burns During the Outbreak of COVID-19

Siyuan Ma et al. Burns. .
Free PMC article

Abstract

COVID-19 is spreading almost all over the world at present, which is caused by the 2019 novel coronavirus (2019-nCoV). It was an epidemic firstly in Hubei province of China. The Chinese government has formally set COVID-19 in the statutory notification and control system for infectious diseases according to the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases. China currently is still struggling to respond to COVID-19 though intensive actions with progress made. The Burn Department of our hospital is one of sections with the highest infectious risk of COVID-19. Based on our own experience and the guidelines on the diagnosis and treatment of COVID-19 (7th Version) with other regulations and literature, we describe our experience with suggestions for medical practices for burn units during the COVID-19 outbreak. We hope these experiences and suggestions benefit our international colleagues during the pandemic of the COVID-19.

Keywords: Burns; COVID-19; Control of infectious epidemic; Experience and suggestion.

Similar articles

See all similar articles

References

    1. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group. bioRxiv. 2020 doi: 10.1101/2020.02.07.937862. [2020-02-24]. https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1. - DOI
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105924. [2020-02-24]. [Published online ahead of print Feb 17,2020] - DOI - PMC - PubMed
    1. National Health Commission of the People’s Republic of China. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th trial ed.) http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf. [in Chinese].
    1. National Health Commission of the People’s Republic of China. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (6th ed.). (2020-02-18) [2020-02-24]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf. [in Chinese].
    1. National Health Commission of the People’s Republic of China. Notice on further strengthening the protection of medical personnel during the epidemic of COVID-19. (2020-02-18) [2020-02-24]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/75c6e88ecbeb42a9a26acb538383e2fc.shtml. [in Chinese].
Feedback